|

Non-Hodgkin Lymphoma - Observational Epidemiological and Clinical Study (NiHiL)

RECRUITINGSponsored by Czech Lymphoma Study Group
Actively Recruiting
SponsorCzech Lymphoma Study Group
Started1999-01-01
Est. completion2020-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03199066

Summary

The Czech National Lymphoma Registry (NiHiL) was founded to monitor epidemiologic data and improve the diagnostic evaluation and quality of treatment of patients with non-Hodgkin´s lymphoma (NHL). The patients are registered into the registry in anonymized form. For each patient are available: registration form, diagnostic form, treatment form, follow- up form, and other malignancy form. Data quality in the NiHiL has been checked by audits. The data is analyzed according to NHL subtypes with endpoints: lymphoma distribution, epidemiological data, prognostic characteristic, treatment characteristics, response rate, relapse rate, mortality, PFS, OS, DFS, Lymphoma specific survival, longterm toxicity.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* lymphoma diagnosis
* treated in the Czech Republic
* signed informed consent

Exclusion Criteria:

* unsigned informed consent
* age \<18 y

Conditions2

CancerNon-Hodgkin Lymphoma (NHL)

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.